Emerging biomarkers: New directions and clinical applications

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 3, 2005, Pages 465-473

  Wurst, Friedrich M ^a   Alling, Christer ^b   Aradottir, Steina ^b   Pragst, Fritz ^c   Allen, John P ^e   Weinmann, Wolfgang ^d   Marmillot, Phillipe ^f   Ghosh, Pradeep ^g,h   Lakshman, Raj ^f,n   Skipper, Gregory E ⁱ   Neumann, Tim ^j   Spies, Claudia ^j   Javors, Martin ^l   Johnson, Bankole A ^m   Ait Daoud, Nassima ^k   Akhtar, Fatema ^k   Roache, John D ^k   Litten, Raye ^f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b LUND UNIVERSITY   (Sweden)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^f GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^g DEPARTMENT OF VETERANS AFFAIRS   (United States)

^h Bio Probes Inc   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^l Mays Cancer Center at UT Health San Antonio   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

more..

Author keywords

Apolipoprotein J; Biomarkers; Carbohydrate Deficient Transferrin; Direct Ethanol Metabolites; Gamma Glutamyl Transferase

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; CARBOHYDRATE; CLUSTERIN; GAMMA GLUTAMYLTRANSFERASE; GLUCURONIDE; SIALIC ACID; TRANSFERRIN;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL PRACTICE; CONFERENCE PAPER; DRINKING BEHAVIOR; FEEDBACK SYSTEM; HIGH RISK PATIENT; MONITORING; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING;

ALCOHOLISM; BIOLOGICAL MARKERS; CLUSTERIN; GLUCURONIDES; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; MONITORING, PHYSIOLOGIC; TREATMENT OUTCOME;

SCOMBERESOX SAURUS SAURUS;

EID: 20144388980     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000156082.08248.AB     Document Type: Conference Paper

References (44)

1. Ait-Daoud NA, Johnson BA, Javors MA, Roache JD, Zanca NA (2001) Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: Corroboration of self-reported drinking by serum CDT, a biomarker. Alcohol Clin Exp Res 25:847-849.
2. Alt A, Janda I, Seidl S, Wurst F M (2000) Ethyl glucuronide can be determined in hair samples of alcoholics. Alcohol Alcohol 35:313-314.
3. Behrens UJ, Worner TM, Braly LF, Schaffner F, Lieber CS (1988) Carbohydrate-deficient transferrin, a marker for chronic alcohol consumption in different ethnic populations. Alcohol Clin Exp Res 12:427-432.
4. Chen J, Conigrave KM, Macaskill P, Whitfield JB, Irwig L (2003) Combining CDT and GGT to increase diagnostic accuracy for problem drinking. Alcohol Alcohol 38:574-582.
5. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: The WHO/ISBRA Collaborative Project. Alcohol Clin Exp Res 26:332-339.
6. Diczfalusy MA, von Wachenfeldt M, Holmberg I, Alexson SEH (2001) Possible role of long chain fatty acid ethyl esters in organ injury and as short-term markers of ethanol intake in humans, in New and Upcoming Markers of Alcohol Consumption (Wurst FM, ed), pp 17-34. Steinkopff-Springer Verlag, Darmstadt.
7. Dresen S, Weinmann W, Wurst FM (2004) forensic confirmatory analysis of ethyl sulfate - a new marker for alcohol consumption - by liquid chromatography/electrospray ionization/tandem mass spectrometry. J Am Soc Mass Spectrom 15:1644-1648.
8. Federation of State Physician Health Programs (2002) www.fsphp.org.
9. Ghosh P, Hale EA, Lakshman MR (1999) Long-term ethanol exposure alters the sialylation index of plasma apolipoprotein J (apoJ) in rats. Alcohol Clin Exp Res 23:720-725.
10. Helander A, Beck O (2004) Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 5:936-937.
11. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 361:1677-1685.
12. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. JAMA 284:963-971.
13. Kapur A, Wild G, Milford-Ward A, Triger DR (1989) Carbohydrate deficient transferrin: A marker for alcohol abuse. BMJ 299:427-431.
14. Laposata M (1999) Assessment of ethanol intake: Current tests and new assays on the horizon. Am J Clin Pathol 112:443-450.
15. Martin MJ, Heymann C, Neumann T, Schmidt L, Soost F, Mazurek B, Bohm B, Marks C, Helling K, Lenzenhuber E, Muller C, Kox WJ, Spies CD (2002) Preoperative evaluation of chronic alcoholics assessed for surgery of the upper digestive tract. Alcohol Clin Exp Res 26:836-840.
16. Meerkerk G-J, Njoo KH, Bongers IMB, Trienekens P, van Oers JAM (1998) The specificity of the CDT assay in general practice: The influence of common chronic diseases and medication on the serum CDT concentration. Alcohol Clin Exp Res 22:908-913.
17. Neumann T, Spies C (2003) Use of biomarkers for alcohol use disorders in clinical practice. Addiction 98(Suppl 2):81-91.
18. Papoz L, Warnet JM, Pequignot G, Eschwege E, Claude JR, Schwartz D (1981) Alcohol consumption in a healthy population: Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. JAMA 245:1748-1751.
19. Sander M, Irwin M, Sinha P, Naumann E, Kox WJ, Spies CD (2002) Suppression of interleukin-6 to interleukin-10 ratio in chronic alcoholics: Association with postoperative infections. Intensive Care Med 28:285-292.
20. Shore JH (1987) The Oregon experience with impaired physicians on probation. JAMA 257:2931-2934.
21. Skipper GE, Schaefer P, Thierauf A, Weinmann W, Allen JP, Miller M, Wurst FM (2004) Detection of surreptitious alcohol use among health professionals recovering from substance-related disorders using a new marker, ethyl glucuronide. Alcohol Alcohol 39:445-459.
22. Skinner HA, Holt S, Israel Y (1981) Early identification of alcohol abuse: Critical issues and psychosocial indicators for a composite index. Can Med Assoc J 124:1141-1152.
23. Spies CD, Emadi A, Neumann T, Hannemann L, Rieger A, Schaffartzik W, Rahmanzadeh R, Berger G, Funk T, Blum S, Müller C, Rommelspacher H (1995) Relevance of carbohydrate-deficient transferrin as a predictor of alcoholism in intensive care patients following trauma. J Trauma 39:742-748.
24. Spies C, von Winterfeld A, Müller C, Rommelspacher H, Neumann T, Marks C, Berger G, Conrad C, Blum S, Hannemann L, Striebel HW, Schaffartzik W (1996a) Reliability of carbohydrate deficient transferrin to detect chronic alcohol misuse in carcinoma patients. Eur Addict Res 2:156-162.
25. Spies CD, Nordmann A, Brummer G, Marks C, Conrad C, Berger G, Runkel N, Neumann T, Muller C, Rommelspacher H, Specht M, Hannemann L, Striebel HW, Schaffartzik W (1996b) Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand 40:649-656.
26. Spies CD, Kissner M, Neumann T, Blum S, Voigt C, Funk T, Runkel N, Pragst F (1998) Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol Alcohol 33:661-999.
27. Spies CD, Herpell J, Beck O, Muller C, Pragst F, Borg S, Helander A (1999) The urinary ratio of 5-hydroxytryptophol to 5-hydroxyindole-3-acetic acid in surgical patients with chronic alcohol misuse. Alcohol 17:19-27.
28. Spies C, Tønnesen H, Andreasson S, Helander A, Conigrave K (2001) Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin Exp Res 25(5 Supple ISBRA), 164S-170S. Review.
29. Spies CD, von Dossow V, Eggers V, Jetschmann G, El-Hilali R, Egert J, Fischer M, Schroder T, Hoflich C, Sinha P, Paschen C, Mirsalim P, Brunsch R, Hopf J, Marks C, Wernecke KD, Pragst F, Ehrenreich H, Muller C, Tonnesen H, Oelkers W, Rohde W, Stein C, Kox WJ (2004) Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology 100:1088-1100.
30. Stibler H, Borg S (1981) Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcohol Clin Exp Res 5:545-549.
31. Stibler H (1991) Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037.
32. Storey EL, Anderson GJ, Mack U, Powell LW, Halliday JW (1987) Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1:1292-1294.
33. Tonnesen H (1999). The alcohol patient and surgery. Alcohol Alcohol 34:148-152.
34. Tønnesen H, Petersen K, Højgaard L, Stokholm KH, Nielsen HJ, Knigge U, Kehlet H (1992) Postoperative morbidity among symptom-free alcohol misusers. Lancet 340:334-337.
35. Varga A, Moller K, Hanson P, Aradottir S, Alling C (2001) Phosphatidylethanol: Clinical significance and biochemical basis, in New and Upcoming Markers of Alcohol Consumption (Wurst FM, ed), pp 75-92. Steinkopff-Springer Verlag, Darmstadt.
36. Vestermark A, Boström H (1959) Studies on ester sulfates: V. On the enzymatic formation of ester sulfates of primary aliphatic alcohols. Exp Cell Res 18:174-177.
37. von Heymann C, Langenkamp J, Dubisz N, von Dossow V, Schaffartzik W, Kern H, Kox WJ, Spies C (2002) Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome. J Trauma 52:95-103.
38. Weinmann W, Schaefer P, Thierauf A, Schreiber A, Wurst FM (2004) Confirmatory analysis of ethyl glucuronide in urine by liquid-chromatography/ electrospray-tandem-mass-spectrometry. J Am Soc Mass Spectrom 15:188-193.
39. Whitfield JB, Fletcher LM, Murphy TL, Powell LW, Halliday J, Heath AC, Martin PR (1998) Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of CDT as a marker of alcohol intake. Clin Chem 44:2480-2489.
40. Witte DP, Aronow BJ, Stauderman ML, Stuart WD, Clay MA, Gruppo RA, Jenkins SH, Harmony JAK (1993) Platelet activation releases megakaryocyte- synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol 143:763-773.
41. Wurst FM, Vogel R, Jachau K, Varga A, Alling C, Skipper GE, Alt A (2003a) Ethyl glucuronide detects recent alcohol use in forensic psychiatric inpatients. Alcohol Clin Exp Res 27:471-476.
42. Wurst FM, Skipper GE, Weinmann W (2003b) Ethyl glucuronide: The direct ethanol metabolite on the threshold from science to routine use. Addiction 98(Suppl 2):51-61.
43. Wurst FM, Alexson S, Wolfersdorf M, Bechtel G, Forster S, Alling C, Aradottir S, Jachau K, Huber P, Allen JP, Auwärter V, Pragst F (2004a) Concentration of fatty acid ethyl esters in hair of alcoholics: Comparison to other biological state markers and self reported ethanol intake. Alcohol Alcohol 39:33-38.
44. Wurst FM, Wiesbeck GA, Metzger JW, Weinmann W, Graf M, on behalf of the WHO/ISBRA study on biological state and trait markers of alcohol use and dependence (2004b) On sensitivity, specificity and the influence of various parameters on ethyl glucuronide levels in urine: Results from the WHO/ISBRA Study. Alcohol Clin Exp Res 28:1220-1228.